TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Campus Pharma AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
270,743
|
212,588
|
165,609 |
| Financial expenses |
670
|
1,364
|
1,131 |
| Earnings before taxes |
30,051
|
-5,157
|
-8,953 |
| EBITDA |
46,809
|
22,714
|
16,486 |
| Total assets |
115,717
|
135,026
|
112,944 |
| Current assets |
109,059
|
109,101
|
67,312 |
| Current liabilities |
65,396
|
70,629
|
48,398 |
| Equity capital |
50,256
|
63,378
|
64,546 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
43
|
38
|
30 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
43.4%
|
46.9%
|
57.1% |
| Turnover per employee |
6,296
|
5,594
|
5,520 |
| Profit as a percentage of turnover |
11.1%
|
-2.4%
|
-5.4% |
| Return on assets (ROA) |
26.5%
|
-2.8%
|
-6.9% |
| Current ratio |
166.8%
|
154.5%
|
139.1% |
| Return on equity (ROE) |
59.8%
|
-8.1%
|
-13.9% |
| Change turnover |
54,323
|
35,227
|
6,362 |
| Change turnover % |
25%
|
20%
|
4% |
| Chg. No. of employees |
5
|
8
|
3 |
| Chg. No. of employees % |
13%
|
27%
|
11% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.